Related Experiment Video
Updated: Apr 12, 2026
06:44
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
8.3K
Reevaluating routine imaging: clinical utility of postoperative CT after stereotactic brain biopsy
Christina Abi Faraj1, Nelson S Moss2, Cheuk Hong Leung3
11Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Journal of Neurosurgery
|April 10, 2026
Summary
Routine postoperative CT scans after stereotactic brain biopsy (SBB) may not be necessary for all patients. A symptom-driven approach can reduce costs and radiation exposure without compromising safety.
Area of Science:
- Neurosurgery
- Radiology
- Medical Imaging
Background:
- Stereotactic brain biopsy (SBB) is a common diagnostic procedure with variable reported postbiopsy hemorrhage rates.
- The necessity of routine postoperative CT scans for hemorrhage detection is debated.
Purpose of the Study:
- To identify factors associated with postbiopsy hemorrhage.
- To evaluate if a selective, symptom-driven imaging strategy can replace routine postoperative CT scans.
Main Methods:
- Retrospective review of 753 SBBs in 751 patients (1993-2021).
- Analysis of hemorrhage presence, neurological symptoms, and clinical/radiographic factors.
- Logistic regression and chi-square analysis to assess variable associations.
Main Results:
- Hemorrhage detected on postoperative CT in 42% of biopsies.
- Factors associated with hemorrhage include early postoperative symptoms, intraoperative bleeding, preoperative intralesional hemorrhage, and specific platelet counts.
- New or worsening neurological symptoms occurred in 21% of cases; 17% positive predictive value for CT in detecting new/expanding hemorrhage.
Conclusions:
- Routine postoperative CT scans after SBB may not be universally required.
- A symptom-driven imaging approach could decrease healthcare costs and radiation exposure.
- Selective imaging is recommended for patients with bleeding diathesis, intraoperative bleeding, intralesional hemorrhage, or new/worsening neurological symptoms.
